JW Pharmaceutical (XKRX:001060) Short-Term Debt : ₩94,166 Mil (As of Mar. 2024)

View and export this data going back to 1976. Start your Free Trial

What is JW Pharmaceutical Short-Term Debt?

JW Pharmaceutical's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩94,166 Mil.

JW Pharmaceutical's quarterly Short-Term Debt declined from Sep. 2023 (₩123,751 Mil) to Dec. 2023 (₩113,134 Mil) and declined from Dec. 2023 (₩113,134 Mil) to Mar. 2024 (₩94,166 Mil).

JW Pharmaceutical's annual Short-Term Debt increased from Dec. 2021 (₩121,800 Mil) to Dec. 2022 (₩206,440 Mil) but then declined from Dec. 2022 (₩206,440 Mil) to Dec. 2023 (₩113,134 Mil).

JW Pharmaceutical Short-Term Debt Historical Data

The historical data trend for JW Pharmaceutical's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

JW Pharmaceutical Short-Term Debt Chart

JW Pharmaceutical Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Short-Term Debt

Get a 7-Day Free Trial

154,952.46

106,466.18

121,800.18

206,439.73

113,134.17

JW Pharmaceutical Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Short-Term Debt	Get a 7-Day Free Trial															248,334.66	165,696.31	123,751.27	113,134.17	94,166.32

JW Pharmaceutical Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

JW Pharmaceutical Short-Term Debt Related Terms

Thank you for viewing the detailed overview of JW Pharmaceutical's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.

JW Pharmaceutical (XKRX:001060) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » JW Pharmaceutical (XKRX:001060) » Definitions » Short-Term Debt

Traded in Other Exchanges

001067:Korea 001065.PFD:Korea

Address

2477, Nambusunhwan-ro, Seocho-gu, KOR

Website

https://www.jw-pharma.co.kr

JW Pharmaceutical is active in the healthcare sector. It has been one of the leading companies in the pharmaceutical market on a global basis. Its original medicine and medical supply pipeline include Livalo, Thrupas, Sigmart and Actemra. It also develops low-protein and low-salt diet food for patients suffering from chronic renal insufficiency as well as general Pharmaceuticals and health care products.

JW Pharmaceutical (XKRX:001060) Headlines

No Headlines